Papp, K. A.; Merola, J. F.; Gottlieb, A. B.; al., E. Dual Neutralization of IL-17A and IL-17F With Bimekizumab Improves Quality of Life in Patients Withmoderate-to-Severe Plaque Psoriasis: Results from a Phase 2b Study and Correlation With Clinical Response. J of Skin 2018, 2, S92.